By Emily Field (December 3, 2020, 10:13 PM EST) -- A group of patients and Johnson & Johnson's pharmaceutical unit told the Judicial Panel on Multidistrict Litigation on Thursday that suits alleging that it concealed a harmful side effect of bladder cyst medicine Elmiron should be heard in New Jersey federal court because the judge there has already been treating the litigation as a mass tort.
Michael London of Douglas & London PC said that from day one, U.S. District Judge Brian Martinotti has treated the cases as a mass tort: Instead of setting individual trials and discovery plans, he implemented procedures and processes to advance the suits as a whole....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!